Skip to main content

Table 2 Total and positive samples obtained in the two groups at each time-point for every site

From: Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial

Sample   T0 T3 T6 T9 T12 T15
Trachea Positive samples in group C 16 18 15 16 11 6
  Positive samples in group N 11 16 12 11 5 1
  Total samples obtained 99 81 72 53 33 22
Stomach Positive samples in group C 29 27 26 16 15 7
  Positive samples in group N 29 21 19 13 9 1
  Total samples obtained 99 86 72 57 37 24
Pharynx Positive samples in group C 23 23 20 18 13 7
  Positive samples in group N 24 22 15 18 11 8
  Total samples obtained 95 73 65 53 33 23
Skin Positive samples in group C 2 3 8 6 6 4
  Positive samples in group N 0 1 4 0 2 2
  Total samples obtained 100 86 72 58 37 28
Rectum Positive samples in group C 13 8 15 13 12 6
  Positive samples in group N 6 7 12 8 1 1
  Total samples obtained 95 79 72 57 33 24
Urine Positive samples in group C 3 6 8 7 7 3
  Positive samples in group N 5 5 5 4 1 0
  Total samples obtained 99 86 72 59 36 28
Blood Positive samples in group C 0 0 0 0 0 0
  Positive samples in group N 0 0 0 0 0 0
  Total samples obtained 99 86 72 59 37 28
  1. Group N, nystatin group; group C, control group.